Asia Pacific Analysis Organoids Market is expected to reach US$ 513.74 Mn by 2027

PRESS RELEASE BY The Insight Partners 04 Feb 2021

Share this press on

Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend in the Organoids Market

According to The Insight Partners market research study of ‘Asia-Pacific Organoids Market to 2027 – Regional Analysis and Forecasts by Type, Application, and Source,’ the Asia-Pacific organoids market is expected to reach US$ 513.74 Mn in 2027 from US$ 97.02 Mn in 2019. The market is estimated to grow with a CAGR of 23.1% from 2020-2027. The report provides trends prevailing in the Asia-Pacific organoids market and the factors driving market along with those that act as hindrances.

Organoid and organ-on-a-chip, which are served as evolving pathological and human physiological relevant in vitro models, hold an excessive potential to revolutionize the conventional example in basic and clinical research. The recent inclination in the collaborative application of organoid with organ-on-a-chip and 3D bio printing enables development of sophisticated cancer models to study underlying mechanisms of tumour-stroma interactions, multi-organ tumour metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit both organoid and organ-on-a-chip benefits and provides a useful tool to study multi-organ tumour metastases and cancer-microenvironment interactions. Overall, researchers expect that these emerging in vitro cancer model systems will ultimately revolutionize the conventional paradigm of cancer research and produce real clinical benefits.

Key driving factor such as rising adoption of bio-banking and tumour modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the market. However, lack of expertise is likely to have a negative impact on the growth of the market in the coming years.

THERMO FISHER SCIENTIFIC, INC., Merck KGaA, CORNING INCORPORATED, STEMCELL Technologies, Inc., and Organoid Therapeutics are some of the leading companies operating in the Asia-Pacific organoids market.

The report segments Asia-Pacific Organoids Market as follows:

Asia-Pacific Organoids Market– By Type

  • Stomach
  • Intestine
  • Liver
  • Pancreas
  • Lung
  • Brain
  • Kidney
  • Others

Asia-Pacific Organoids Market– By Application

  • Developmental Biology
  • Disease Pathology of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity and Efficacy Testing
  • Drug Discovery and Personalized Medicine
  • Others

Asia-Pacific Organoids Market – By End User

  • Pluripotent Stem Cells
  • Organ-specific Adult Stem Cells

Asia-Pacific Organoids Market– By Geography

  • Asia-Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia

Contact Us
Phone: +1-646-491-9876
Email Id:

Download Free PDF Brochure